Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMM GROUP LIMITED Capital/Financing Update 2015

Oct 26, 2015

65078_rns_2015-10-26_bcbf4b6f-7375-444c-bea4-d27b0ae82820.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

FlexiGroup Limited

ABN

75 122 574 583

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{1}$ + Class of + securities issued or to
be issued
Fully paid ordinary shares
$\overline{2}$ Number of + securities issued or
be issued (if known) or
to
maximum number which may
be issued
Approximately 68,195,002 fully paid
ordinary shares (New Shares) pursuant to
the terms of the accelerated, non-
renounceable entitlement offer (the
Entitlement Offer ) described in the
announcement and investor presentation
lodged with ASX on 27 October 2015 (the
ASX Materials ).
The final number of New Shares issued and
the split of those New Shares between the
institutional component and retail
component of the Entitlement Offer
remains subject to rounding and the
reconciliation of shareholder entitlements.

+ See chapter 19 for defined terms.

$\overline{\mathbf{3}}$ Principal terms of the +securities
(e.g. if options, exercise price
and expiry date; if partly paid
the
+securities,
amount
outstanding and due dates for
if
payment;
+convertible
securities, the conversion price
and dates for conversion)
The New Shares will have the same terms as
existing fully paid ordinary shares.
$\overline{4}$ Do the + securities rank equally
in all respects from the + issue
date with an existing + class of
quoted +securities?
If the additional + securities do
not rank equally, please state:
the date from which they do
the extent to which they
۰
participate for the
next
dividend, (in the case of a
distribution)
trust,
or
interest payment
the extent to which they do
not rank equally, other than
in relation to the next
dividend, distribution
or
interest payment
Yes, the New Shares will rank equally with
existing fully paid ordinary shares from the
date of allotment.
5 Issue price or consideration A\$2.20 per New Share
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
The proceeds from the Entitlement Offer are
expected to be \$150,029,004 and will be
used to partially fund the acquisition of a
100% interest in Fisher & Paykel Finance
Holdings Limited.
For more information, please refer to the
ASX Materials.
6a Is the entity an + eligible entity
obtained
that
has
security
holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h
in relation to the + securities the
subject of this Appendix 3B, and
N/A

$\label{eq:2.1} \frac{1}{2} \sum_{i=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{1}{2} \sum_{j=1}^n \frac{$

$\mathcal{L}^{\text{max}}_{\text{max}}$

  • Number of +securities issued without security holder approval under rule 7.1
  • Number of +securities issued $6d$ with security holder approval under rule 7.1A
  • Number of +securities issued | 6e with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
  • 6f Number of +securities issued $N/A$ under an exception in rule 7.2
  • If +securities issued under rule $6g$ 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.
  • $6h$ If +securities were issued under rule $7.1A$ for non-cash consideration, state date on which valuation $\sigma$ consideration was released to ASX Market Announcements
  • Calculate the entity's remaining 6i issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

+Issue dates $\overline{7}$

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Number and +class of all 8 *securities quoted on ASX (including the +securities in section 2 if applicable)

Entitlement Offer - Friday 6 November 2015

Offer - Tuesday 24 November 2015

$N/A$

For the institutional component of the

For the retail component of the Entitlement

Number + Class
Approximately Fully paid ordinary
372,344,709 shares

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

Number + Class
$\mathbf Q$ Number and + class of all
+ securities not quoted on ASX
(including the + securities in
section 2 if applicable)
4,030,083 Options
Performance Rights
over Shares
and
10 Dividend policy (in the case of a $\vert$ No change.

Part 2 - Pro rata issue

trust, distribution policy) on the increased capital (interests)

11 holder
approval
security
Is
required?
No, shareholder approval is not required for the
Entitlement Offer.
12 Is the issue renounceable or non-
renounceable?
Non-renounceable
13 Ratio in which the + securities
will be offered
The entitlement ratio for existing shareholders
is 1 New Share for every 4.46 existing fully paid
ordinary shares held at the record date for the
Entitlement Offer.
14 + Class of + securities to which the
offer relates
Fully paid ordinary shares
15 determine
+Record date
to
entitlements
7:00pm (AEST), Friday 30 October 2015
16 different
holdings
Will
on
registers (or subregisters) be
calculating
aggregated
for
entitlements?
N o
17 Policy for deciding entitlements
in relation to fractions
Where fractions arise in the calculation of
shareholders' entitlements under the
Entitlement Offer they will be rounded up to
the next whole number of New Shares.
18 Names of countries in which the
entity has security holders who
will not be sent new
offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
For the institutional component of the
Entitlement Offer, all countries other than
Australia, New Zealand, Germany,
Netherlands, France, Hong Kong, Ireland,
Italy, Norway, Singapore, Switzerland, an
United Kingdom.
the retail component
For
of
the
Entitlement Offer - all countries other than
Australia and New Zealand.
19 Closing date for receipt
of
acceptances or renunciations
For the institutional component of the
Entitlement Offer - Wednesday 28 October
2015.
For the retail component of the
Entitlement Offer - Monday 16 November
2015

$\ddot{\phantom{a}}$

+ See chapter 19 for defined terms.

20 Names of any underwriters Citigroup Global Markets Pty Limited
CBA Equities Limited
21 Amount of any underwriting fee
or commission
An underwriting fee of 1.8% of the proceeds
of the gross proceeds of the Entitlement
the
Offer
less
commitment
from
Abercrombie
Group Pty Ltd and its
associates, plus
A management and selling fee of 0.6% of
the gross proceeds of the Entitlement Offer
less the proceeds from Abercrombie Group
Pty Ltd and its associates
22 Names of any brokers to the
issue
N/A
23 Fee or commission payable to the
broker to the issue
N/A
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
N/A
25 If the issue is contingent on
security holders' approval, the
date of the meeting
N/A
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
No prospectus is being prepared in connection
with the Entitlement Offer. A retail offer
document and personalised entitlement and
acceptance form will be sent to eligible
shareholders on or after Wednesday 4
November 2015.
27 If the entity has issued options,
and the terms entitle option
holders
participate
to
on
exercise, the date on
which
notices will be sent to option
holders
N/A
28 Date rights trading will begin (if
applicable)
N/A
29 Date rights trading will end (if
applicable)
N/A

$\mathcal{L}_{\mathcal{A}}$ is

+ See chapter 19 for defined terms.

30 How do security holders sell
their entitlements in full through
a broker?
N/A
31 How do security holders sell part
of their entitlements through a
broker and accept for the
balance?
N/A
32 How do security holders dispose
of their entitlements (except by
sale through a broker)?
N/A
33 + Issue date For the institutional component of the
Entitlement Offer - Friday 6 November
2015
For the retail component of the
Entitlement Offer - Tuesday 24 November
2015

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • Type of +securities 34 (tick one)
  • Securities described in Part 1
  • $(b)$

$(a)$

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35
  • If the 'securities are 'equity securities, the names of the 20 largest holders of the additional *securities, and the number and percentage of additional *securities held by those holders
  • 36 If the *securities are *equity securities, a distribution schedule of the additional *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$

+ See chapter 19 for defined terms.

10,001 - 100,000 100,001 and over

A copy of any trust deed for the additional +securities

Entities that have ticked box 34(b)

37

38 Number of + securities for which
+ quotation is sought
N/A
39 + Class of + securities for which
quotation is sought
N/A
40 Do the + securities rank equally in
all respects from the + issue date
with an existing + class of quoted
+ securities?
N/A
If the additional + securities do not
rank equally, please state:
the date from which they do
to which
the extent
they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
the extent to which they do
$\bullet$
not rank equally, other than in
relation to the next dividend,
distribution
interest
Or
payment
41 Reason for request for quotation
now
Example: In the case of restricted securities, end
of restriction period
N/A
(if issued upon conversion of
another + security, clearly identify
that other 'security)
42 and + class
of
Number
all
quoted on
+ securities
ASX
(including the + securities in clause
38)
Number
N/A
+ Class
N/A

+ See chapter 19 for defined terms.

Quotation agreement

  • *Quotation of our additional *securities is in ASX's absolute discretion. ASX $\mathbf{I}$ may quote the +securities on any conditions it decides.
  • We warrant the following to ASX. $\overline{2}$
  • The issue of the *securities to be quoted complies with the law and is $\bullet$ not for an illegal purpose.
  • There is no reason why those +securities should not be granted $\bullet$ +quotation.
  • An offer of the *securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to $\bullet$ any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • We will indemnify ASX to the fullest extent permitted by law in respect of any 3 claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any $\overline{4}$ information or document is not available now, we will give it to ASX before *quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: Injay-Anderson
.
(Director/Company secretary)
Date: $27/10/15$
Print name: JULIANNE LYALL-ANDERSON

+ See chapter 19 for defined terms.

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid +ordinary
securities on issue 12 months before the
*issue date or date of agreement to issue
Add the following:
Number of fully paid + ordinary securities
issued in that 12 month period under an
exception in rule 7.2
Number of fully paid + ordinary securities
issued in that 12 month period with
shareholder approval
Number of partly paid +ordinary
$\bullet$
securities that became fully paid in that
12 month period
Note:
Include only ordinary securities here -
other classes of equity securities cannot
be added
Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
۰
securities on different dates as separate
line items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month
period
"A"

+ See chapter 19 for defined terms.

Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15
Step 3: Calculate "C", the amount of placement capacity under rule
7.1 that has already been used
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
Under an exception in rule 7.2
Under rule 7.1A
With security holder approval under rule
$\bullet$
7.1 or rule 7.4
Note:
This applies to equity securities, unless
$\bullet$
specifically excluded - not just ordinary
securities
Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
$\bullet$
securities on different dates as separate
line items
"C"
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
$A'' \times 0.15$
Note: number must be same as shown in
Step 2
Subtract "C"
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.15] - "C"
[Note: this is the remaining placement
capacity under rule 7.1]

+ See chapter 19 for defined terms.

Part 2

Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
Multiply "A" by 0.10
Step 3: Calculate "E", the amount of placement capacity under rule
7.1A that has already been used
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
This applies to equity securities - not
just ordinary securities
Include here $-$ if applicable $-$ the
$\bullet$
securities the subject of the Appendix
3B to which this form is annexed
Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
It may be useful to set out issues of
securities on different dates as separate
line items
"F"

+ See chapter 19 for defined terms.

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
$A'' \times 0.10$
Note: number must be same as shown in
Step 2
Subtract "E"
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.10] – "E"
Note: this is the remaining placement
capacity under rule 7.1A

$\ddot{\phantom{a}}$

+ See chapter 19 for defined terms.